DiaMedica Therapeutics Inc. Common Stock

$6.02
-0.01 (-0.17%)

Volume:

74.516K ($448.59K)

Market Capitalization:

$324.37M

DiaMedica Therapeutics Price Chart

DiaMedica Therapeutics Price Chart6:57 AM8:17 AM9:37 AM10:57 AM12:17 PM1:37 PM2:57 PM6.046.005.965.935.895.855.82

DiaMedica Therapeutics Volume Chart

DiaMedica Therapeutics Volume Chart6:57 AM8:17 AM9:37 AM10:57 AM12:17 PM1:37 PM2:57 PM10.16K8.71K7.25K5.80K4.35K2.90K1.45K

DiaMedica Therapeutics Market Segments

Regular Trading Hours

-0.02(-0.33%)
Open$6.04
Close$6.02
Low$5.81
Low Change-0.23 (-3.81%)
High$6.04
High Change+0.00 (+0.00%)
Range$0.23
Volume74.516K
Dollar Volume$448.59K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$6.05
Close$6.05
Low$6.05
Low Change0.00 (0.00%)
High$6.05
High Change+0.00 (+0.00%)
Range$0.00
Volume400
Dollar Volume$2.42K

Regular Trading Hours Yesterday

+0.07(+1.17%)
Open$5.96
Close$6.03
Low$5.89
Low Change-0.07 (-1.17%)
High$6.20
High Change+0.24 (+4.03%)
Range$0.31
Volume150.534K
Dollar Volume$907.72K

Premarket Yesterday

-0.14(-2.30%)
Open$6.10
Close$5.96
Low$5.96
Low Change-0.14 (-2.30%)
High$6.10
High Change+0.00 (+0.00%)
Range$0.14
Volume1.944K
Dollar Volume$11.59K

DiaMedica Therapeutics Moving Averages

5 Day Moving Average (SMA5)$6.17
10 Day Moving Average (SMA10)$6.33
20 Day Moving Average (SMA20)$6.37
50 Day Moving Average (SMA50)$7.04
100 Day Moving Average (SMA100)$7.72
200 Day Moving Average (SMA200)$7.00

DiaMedica Therapeutics Statistics

Average Volume (30 Days)205.56K
P/E Ratio (Current)-10.20
EPS (Current)-$0.61
Dividend Yield0.00%
Free Cash Flow-$29.10M
Cash Ratio3.05
Current Ratio11.81
Quick Ratio11.81
Debt to Equity0.00
Enterprise Value$319.52M
EV to EBITDA-9.30
EV to Sales
Price to Book5.97
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.53%
Return on Equity-0.58%

DiaMedica Therapeutics Stock Splits

There have been no stock splits for DiaMedica Therapeutics (DMAC).

DiaMedica Therapeutics Dividends

There have been no dividends for DiaMedica Therapeutics (DMAC).